MitraClip Implantation for Functional Mitral Regurgitation With Coaptation Gap Facilitated by Levosimendan Treatment

• Main Authors: Athanasios Koutsoukis, MD, Damien Fard, MD, Romain Gallet, MD, PhD, Madjid Boukantar, MD, Emmanuel Teiger, MD, PhD, Annabelle Nguyen, MD, Raphaelle Huguet, MD, Pascal Lim, MD, PhD
• Format: Article
• Language: English
• Published: Elsevier 2020-06-01
• Series: JACC: Case Reports
• Subjects: heart failure; levosimendan; MitraClip; mitral regurgitation
• Online Access: http://www.sciencedirect.com/science/article/pii/S266608492030379X
• ISSN: 2666-0849

A patient with severe, symptomatic functional mitral regurgitation was initially considered not suitable for MitraClip (Abbott Vascular, Abbott Park, Illinois) implantation because of non-coapting mitral leaflets. Repeated levosimendan infusions in combination with intensive diuresis induced sufficient valve coaptation, thus allowing MitraClip implantation to be performed. (Level of Difficulty: Intermediate.)